Post-marketing safety evaluation of the live-attenuated chikungunya vaccine (IXCHIQ).
- DOI
- 10.1016/j.vaccine.2026.128491
- Published
- 2026 Apr 19
- Container
- Vaccine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.vaccine.2026.128491,
title = {Post-marketing safety evaluation of the live-attenuated chikungunya vaccine (IXCHIQ).},
author = {Vondeling GT and Croda J and Jelinek T and Kassianos G and Kollaritsch H and Nguyen LBL and Ribeiro GS and Schmidt-Chanasit J and Thomas SJ and Unger Z and de Roo A and Plennevaux E and Jaramillo JC},
year = {2026},
journal = {Vaccine},
doi = {10.1016/j.vaccine.2026.128491},
url = {https://doi.org/10.1016/j.vaccine.2026.128491}
}RIS
TY - JOUR TI - Post-marketing safety evaluation of the live-attenuated chikungunya vaccine (IXCHIQ). AU - Vondeling GT AU - Croda J AU - Jelinek T AU - Kassianos G AU - Kollaritsch H AU - Nguyen LBL AU - Ribeiro GS AU - Schmidt-Chanasit J AU - Thomas SJ AU - Unger Z AU - de Roo A AU - Plennevaux E AU - Jaramillo JC PY - 2026 JO - Vaccine DO - 10.1016/j.vaccine.2026.128491 UR - https://doi.org/10.1016/j.vaccine.2026.128491 ER -
APA
GT, V., J, C., T, J., G, K., H, K., LBL, N., GS, R., J, S., SJ, T., Z, U., A, D. R., E, P., & JC, J. (2026). Post-marketing safety evaluation of the live-attenuated chikungunya vaccine (IXCHIQ).. Vaccine. https://doi.org/10.1016/j.vaccine.2026.128491
Source records
- pubmed · retrieved 2026-09-26T01:52:41.918Z